RN7SL167P

RNA — tumor vs normal
Tumor vs NormalRNABox plot · TCGA cohorts

Across TCGA pan-cancer cohorts, RN7SL167P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RN7SL167P’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where RN7SL167P RNA is repressed in tumor relative to normal tissue. In most cancer types RN7SL167P is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.

BRCA and LUSC are the cancer types where RN7SL167P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL167P RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.
LineageGenderStageFold-changepSampling consensus
BRCAAllAll−0.040.0092view →
LUSCAllAll+0.031.0331view →
Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

RN7SL167P–BRCA

Tumor-vs-normal expression box plot for RN7SL167P RNA in BRCA.

Open the BRCA breakdown →

Exploration